EUVIMEDEUVIMED entdecken
Crossref

Blood laboratory parameters can predict relapse-free survival of patients with advanced squamous cell lung cancer and adenocarcinoma

Anatoli D. Tahanovich, Mikalai M. Kauhanka, Alexander V. Kolb, Oxana V. Gotko, Violetta I. Prokharova

Global Translational Medicine · 2024

DOI: 10.36922/gtm.4865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Translational Medicine, 2024. Verfasst von Anatoli D. Tahanovich und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of the work was to study the relationship between the concentration of cells and proteins in the blood of patients with Stage III squamous cell lung cancer (SCLC) and adenocarcinoma (AC) before surgical treatment and the duration of the relapse-free period after tumor resection to develop prognostic models for relapse-free survival in these diseases. Using logistic regression equations, the models incorporated variables included cytokeratin 19 fragment antigen 21-1 (CYFRA 21-1) concentration, the proportion of lymphocytes expressing the C-X-C motif chemokine receptor 1 (CXCR1), and monocytes expressing the C-X-C motif chemokine receptor 2 for SCLC. For AC, the models included the CYFRA 21-1 concentration, lymphocytes expressing the CXCR1 receptor, and the eosinophil-to-monocyte ratio. These models can predict the probability of tumor recurrence based on measurements of blood parameters in the pre-operative period, with a prediction efficiency of 87.7% for SCLC and 89.0% for AC.

Zitieren

APA

Tahanovich, A. D., Kauhanka, M. M., Kolb, A. V., Gotko, O. V., & Prokharova, V. I. (2024). Blood laboratory parameters can predict relapse-free survival of patients with advanced squamous cell lung cancer and adenocarcinoma. Global Translational Medicine. https://doi.org/10.36922/gtm.4865

Vancouver

Tahanovich AD, Kauhanka MM, Kolb AV, Gotko OV, Prokharova VI. Blood laboratory parameters can predict relapse-free survival of patients with advanced squamous cell lung cancer and adenocarcinoma. Global Translational Medicine. 2024. doi:10.36922/gtm.4865

BibTeX
@article{Tahanovich2024,
  author = {Tahanovich, Anatoli D. and Kauhanka, Mikalai M. and Kolb, Alexander V. and Gotko, Oxana V. and Prokharova, Violetta I.},
  title = {Blood laboratory parameters can predict relapse-free survival of patients with advanced squamous cell lung cancer and adenocarcinoma},
  journal = {Global Translational Medicine},
  year = {2024},
  doi = {10.36922/gtm.4865}
}
Kostenlos starten →